Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.
2.

Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean.

McCue P, Kwon YI, Shetty K.

Asia Pac J Clin Nutr. 2005;14(2):145-52.

3.
4.

Phenolic-rich extracts from selected tropical underutilized legumes inhibit α-amylase, α-glucosidase, and angiotensin I converting enzyme in vitro.

Ademiluyi AO, Oboh G.

J Basic Clin Physiol Pharmacol. 2012 Jan 19;23(1):17-25. doi: 10.1515/jbcpp-2011-0005.

PMID:
22865445
5.

Functionality of bioactive compounds in Brazilian strawberry (Fragaria x ananassa Duch.) cultivars: evaluation of hyperglycemia and hypertension potential using in vitro models.

da Silva Pinto M, Kwon YI, Apostolidis E, Lajolo FM, Genovese MI, Shetty K.

J Agric Food Chem. 2008 Jun 25;56(12):4386-92. doi: 10.1021/jf0732758.

PMID:
18522404
6.

Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension.

Kwon YI, Vattem DA, Shetty K.

Asia Pac J Clin Nutr. 2006;15(1):107-18.

7.

In vitro studies of Gynura divaricata (L.) DC extracts as inhibitors of key enzymes relevant for type 2 diabetes and hypertension.

Wu T, Zhou X, Deng Y, Jing Q, Li M, Yuan L.

J Ethnopharmacol. 2011 Jun 22;136(2):305-8. doi: 10.1016/j.jep.2011.04.059.

PMID:
21570455
8.
9.
10.

Phenolic-linked variation in strawberry cultivars for potential dietary management of hyperglycemia and related complications of hypertension.

Cheplick S, Kwon YI, Bhowmik P, Shetty K.

Bioresour Technol. 2010 Jan;101(1):404-13. doi: 10.1016/j.biortech.2009.07.068.

PMID:
19695871
11.

Potential of Ginkgo biloba L. leaves in the management of hyperglycemia and hypertension using in vitro models.

Pinto Mda S, Kwon YI, Apostolidis E, Lajolo FM, Genovese MI, Shetty K.

Bioresour Technol. 2009 Dec;100(24):6599-609. doi: 10.1016/j.biortech.2009.07.021.

PMID:
19665890
12.

In vitro potential of Ascophyllum nodosum phenolic antioxidant-mediated alpha-glucosidase and alpha-amylase inhibition.

Apostolidis E, Lee CM.

J Food Sci. 2010 Apr;75(3):H97-102. doi: 10.1111/j.1750-3841.2010.01544.x.

PMID:
20492300
13.

Health benefits of traditional corn, beans, and pumpkin: in vitro studies for hyperglycemia and hypertension management.

Kwon YI, Apostolidis E, Kim YC, Shetty K.

J Med Food. 2007 Jun;10(2):266-75.

PMID:
17651062
15.

Inhibitory activity on type 2 diabetes and hypertension key-enzymes, and antioxidant capacity of Veronica persica phenolic-rich extracts.

Sharifi-Rad M, Tayeboon GS, Sharifi-Rad J, Iriti M, Varoni EM, Razazi S.

Cell Mol Biol (Noisy-le-grand). 2016 May 30;62(6):80-5.

PMID:
27262808
16.

Anti-hyperglycemia properties of Tea (Camellia sinensis) bioactives using in vitro assay models and influence of extraction time.

Ankolekar C, Terry T, Johnson K, Johnson D, Barbosa AC, Shetty K.

J Med Food. 2011 Oct;14(10):1190-7. doi: 10.1089/jmf.2010.0291.

PMID:
21859352
17.

In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.

Deo P, Hewawasam E, Karakoulakis A, Claudie DJ, Nelson R, Simpson BS, Smith NM, Semple SJ.

BMC Complement Altern Med. 2016 Nov 4;16(1):435.

18.
19.
20.

Antidiabetes and antihypertension potential of commonly consumed carbohydrate sweeteners using in vitro models.

Ranilla LG, Kwon YI, Genovese MI, Lajolo FM, Shetty K.

J Med Food. 2008 Jun;11(2):337-48. doi: 10.1089/jmf.2007.689.

PMID:
18598178

Supplemental Content

Support Center